Oncoimmunology

Keyphrases

Publications

volume 13, number 1, 2024

Mimi Zhou, Yali Feng, Xiaoli Zhang, Jianguo Chen, Naijuan Yao, Shan Fu, Tianzhi Ni, Yi Chen, Fei Xie, Sahasrabda Roy, Jinfeng Liu, Yuan Yang, Yingli He, Yingren Zhao, Nan Yang
Platelet-derived microparticles adoptively transfer integrin β3 to promote antitumor effect of tumor-infiltrating T cells. Oncoimmunology 13 (1) (2024)
Manuela Lizarralde-Guerrero, Laura Zucaro, Guido Kroemer, Jonathan G Pol
Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity. Oncoimmunology 13 (1) (2024)
Erin M Dickey, Anna Bianchi, Haleh Amirian, Peter J Hosein, Denise Faustman, Roberta Brambilla, Jashodeep Datta
Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer. Oncoimmunology 13 (1) (2024)
Yikun Li, Peiliang Wang, Junhao Xu, Xiaonan Shi, Tianwen Yin, Feifei Teng
Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition. Oncoimmunology 13 (1) (2024)
Zoltan Szallasi, Aurel Prosz, Zsofia Sztupinszki, Judit Moldvay
Are tumor-associated carbohydrates the missing link between the gut microbiome and response to immune checkpoint inhibitor treatment in cancer? Oncoimmunology 13 (1) (2024)
Mimi Zhou, Yali Feng, Xiaoli Zhang, Jianguo Chen, Naijuan Yao, Shan Fu, Tianzhi Ni, Yi Chen, Fei Xie, Sahasrabda Roy, Jinfeng Liu, Yuan Yang, Yingli He, Yingren Zhao, Nan Yang
Platelet-derived microparticles adoptively transfer integrin β3 to promote antitumor effect of tumor-infiltrating T cells. Oncoimmunology 13 (1) (2024)
Carlo P Ramil, Handan Xiang, Peng Zhang, Aileen Cronin, Lisia Cabral, Zhizhang Yin, Josephine Hai, Huijun Wang, Benjamin Ruprecht, Yanlin Jia, Dongyu Sun, Hongmin Chen, An Chi
Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function. Oncoimmunology 13 (1) (2024)
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, Lucillia Bezu
Trial watch: local anesthetics in cancer therapy. Oncoimmunology 13 (1) (2024)
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, Lucillia Bezu
Trial watch: dexmedetomidine in cancer therapy. Oncoimmunology 13 (1) (2024)
Erin M Dickey, Anna Bianchi, Haleh Amirian, Peter J Hosein, Denise Faustman, Roberta Brambilla, Jashodeep Datta
Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer. Oncoimmunology 13 (1) (2024)
Patrik Sundström, Nikita Dutta, William Rodin, Andreas Hallqvist, Sukanya Raghavan, Marianne Quiding-Järbrink
Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer. Oncoimmunology 13 (1) (2024)
Wei Wei, Linqing Tian, Xiaoyan Zheng, Lei Zhong, Yuan Chen, Hui Dong, Guibing Zhang, Shibing Wang, Xiangmin Tong
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8 + T cell function and its impact against pancreatic ductal adenocarcinoma. Oncoimmunology 13 (1) (2024)
Diana I Albu, Benjamin J Wolf, Yan Qin, Xianzhe Wang, Amy Daniel Ulumben, Mei Su, Vivian Li, Eirene Ding, Jose Angel Gonzalo, Jason Kong, Ruturaj Jadhav, Nelly Kuklin, Alberto Visintin, Bing Gong, Thomas J Schuetz
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity. Oncoimmunology 13 (1) (2024)
Ying Zheng, Andriana Lebid, Liam Chung, Juan Fu, Xiaoxu Wang, Andrea Otrocol, Jelani C Zarif, Hong Yu, Nicolas J Llosa, Drew M Pardoll
Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy. Oncoimmunology 13 (1) (2024)
Hannah Jorinde Glöckner, Evelina Martinenaite, Thomas Landkildehus Lisle, Jacob Grauslund, Shamaila Ahmad, Özcan Met, Per Thor Straten, Mads Hald Andersen
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells. Oncoimmunology 13 (1) (2024)
Manuela Lizarralde-Guerrero, Laura Zucaro, Guido Kroemer, Jonathan G Pol
Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity. Oncoimmunology 13 (1) (2024)
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, Lucillia Bezu
Trial watch: local anesthetics in cancer therapy. Oncoimmunology 13 (1) (2024)
Margot Revel, Mikel Rezola Artero, Houcine Hamidi, Anne Grunenwald, Loris Blasco, Yann A Vano, Stephane Marie Oudard, Rafael Sanchez-Salas, Petr Macek, Lara Rodriguez Sanchez, Xavier Cathelineau, Benoit Vedié, Catherine Sautes-Fridman, Wolf Herman Fridman, Lubka T Roumenina, Marie-Agnes Dragon-Durey
Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression. Oncoimmunology 13 (1) (2024)
Reshmi Nair, Tamsin R M Lannagan, Rene Jackstadt, Anna Andrusaite, John Cole, Caitlin Boyne, Robert J B Nibbs, Owen J Sansom, Simon Milling
Co-inhibition of TGF-β and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance. Oncoimmunology 13 (1) (2024)
Marcus Bauer, Nadja Jäkel, Andreas Wilfer, Anja Haak, Markus Eszlinger, Katalin Kelemen, Monika Haemmerle, Haifa Kathrin Al-Ali, Barbara Seliger, Claudia Wickenhauser
Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAML. Oncoimmunology 13 (1) (2024)
Erin M Dickey, Anna Bianchi, Haleh Amirian, Peter J Hosein, Denise Faustman, Roberta Brambilla, Jashodeep Datta
Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer. Oncoimmunology 13 (1) (2024)
Giulio Cassanello, Alejandro Luna de Abia, Lorenzo Falchi
Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma. Oncoimmunology 13 (1) (2024)
Marcus Bauer, Nadja Jäkel, Andreas Wilfer, Anja Haak, Markus Eszlinger, Katalin Kelemen, Monika Haemmerle, Haifa Kathrin Al-Ali, Barbara Seliger, Claudia Wickenhauser
Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAML. Oncoimmunology 13 (1) (2024)
Wei Wei, Linqing Tian, Xiaoyan Zheng, Lei Zhong, Yuan Chen, Hui Dong, Guibing Zhang, Shibing Wang, Xiangmin Tong
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8 + T cell function and its impact against pancreatic ductal adenocarcinoma. Oncoimmunology 13 (1) (2024)
Giulio Cassanello, Alejandro Luna de Abia, Lorenzo Falchi
Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma. Oncoimmunology 13 (1) (2024)
Yikun Li, Peiliang Wang, Junhao Xu, Xiaonan Shi, Tianwen Yin, Feifei Teng
Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition. Oncoimmunology 13 (1) (2024)
Jin Su, Xinyuan Mao, Lingzhi Wang, Zhian Chen, Weisheng Wang, Cuiyin Zhao, Guoxin Li, Weihong Guo, Yanfeng Hu
Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer. Oncoimmunology 13 (1) (2024)
Diana I Albu, Benjamin J Wolf, Yan Qin, Xianzhe Wang, Amy Daniel Ulumben, Mei Su, Vivian Li, Eirene Ding, Jose Angel Gonzalo, Jason Kong, Ruturaj Jadhav, Nelly Kuklin, Alberto Visintin, Bing Gong, Thomas J Schuetz
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity. Oncoimmunology 13 (1) (2024)
Patrik Sundström, Nikita Dutta, William Rodin, Andreas Hallqvist, Sukanya Raghavan, Marianne Quiding-Järbrink
Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer. Oncoimmunology 13 (1) (2024)
Min Ma, Liang Li, Shu-Han Yang, Chuan Huang, Weitao Zhuang, Shujie Huang, Xin Xia, Yong Tang, Zijun Li, Zhi-Bin Zhao, Qingyun Chen, Guibin Qiao, Zhe-Xiong Lian
Lymphatic endothelial cell-mediated accumulation of CD177 + Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma. Oncoimmunology 13 (1) (2024)
Leqian Ying, Zhangmin Hu, Yi Lu, Qing Tao, Fen Xiong, Yongqian Shu, Yufei Yang, Xuehan Qiao, Chen Peng, Yuchun Jiang, Miao Han, Min Xu, Xiaoqin Li, Deqiang Wang
An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherapy outcomes. Oncoimmunology 13 (1) (2024)
Ying Zheng, Andriana Lebid, Liam Chung, Juan Fu, Xiaoxu Wang, Andrea Otrocol, Jelani C Zarif, Hong Yu, Nicolas J Llosa, Drew M Pardoll
Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy. Oncoimmunology 13 (1) (2024)
Leqian Ying, Zhangmin Hu, Yi Lu, Qing Tao, Fen Xiong, Yongqian Shu, Yufei Yang, Xuehan Qiao, Chen Peng, Yuchun Jiang, Miao Han, Min Xu, Xiaoqin Li, Deqiang Wang
An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherapy outcomes. Oncoimmunology 13 (1) (2024)
Meishi Zhong, Manmei Long, Chenjie Han, Saiyan Ji, Qingyuan Yang
STING is significantly increased in high-grade glioma with high risk of recurrence. Oncoimmunology 13 (1) (2024)
Carlo P Ramil, Handan Xiang, Peng Zhang, Aileen Cronin, Lisia Cabral, Zhizhang Yin, Josephine Hai, Huijun Wang, Benjamin Ruprecht, Yanlin Jia, Dongyu Sun, Hongmin Chen, An Chi
Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function. Oncoimmunology 13 (1) (2024)
Meishi Zhong, Manmei Long, Chenjie Han, Saiyan Ji, Qingyuan Yang
STING is significantly increased in high-grade glioma with high risk of recurrence. Oncoimmunology 13 (1) (2024)
Vikram S Pothuri, Graham D Hogg, Leah Conant, Nicholas Borcherding, C Alston James, Jacqueline Mudd, Greg Williams, Yongwoo David Seo, William G Hawkins, Venu G Pillarisetty, David G DeNardo, Ryan C Fields
Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma. Oncoimmunology 13 (1) (2024)
Min Ma, Liang Li, Shu-Han Yang, Chuan Huang, Weitao Zhuang, Shujie Huang, Xin Xia, Yong Tang, Zijun Li, Zhi-Bin Zhao, Qingyun Chen, Guibin Qiao, Zhe-Xiong Lian
Lymphatic endothelial cell-mediated accumulation of CD177 + Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma. Oncoimmunology 13 (1) (2024)
Margot Revel, Mikel Rezola Artero, Houcine Hamidi, Anne Grunenwald, Loris Blasco, Yann A Vano, Stephane Marie Oudard, Rafael Sanchez-Salas, Petr Macek, Lara Rodriguez Sanchez, Xavier Cathelineau, Benoit Vedié, Catherine Sautes-Fridman, Wolf Herman Fridman, Lubka T Roumenina, Marie-Agnes Dragon-Durey
Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression. Oncoimmunology 13 (1) (2024)
Vikram S Pothuri, Graham D Hogg, Leah Conant, Nicholas Borcherding, C Alston James, Jacqueline Mudd, Greg Williams, Yongwoo David Seo, William G Hawkins, Venu G Pillarisetty, David G DeNardo, Ryan C Fields
Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma. Oncoimmunology 13 (1) (2024)
Hannah Jorinde Glöckner, Evelina Martinenaite, Thomas Landkildehus Lisle, Jacob Grauslund, Shamaila Ahmad, Özcan Met, Per Thor Straten, Mads Hald Andersen
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells. Oncoimmunology 13 (1) (2024)
Reshmi Nair, Tamsin R M Lannagan, Rene Jackstadt, Anna Andrusaite, John Cole, Caitlin Boyne, Robert J B Nibbs, Owen J Sansom, Simon Milling
Co-inhibition of TGF-β and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance. Oncoimmunology 13 (1) (2024)
Giulio Cassanello, Alejandro Luna de Abia, Lorenzo Falchi
Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma. Oncoimmunology 13 (1) (2024)
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, Lucillia Bezu
Trial watch: dexmedetomidine in cancer therapy. Oncoimmunology 13 (1) (2024)
Min Ma, Liang Li, Shu-Han Yang, Chuan Huang, Weitao Zhuang, Shujie Huang, Xin Xia, Yong Tang, Zijun Li, Zhi-Bin Zhao, Qingyun Chen, Guibin Qiao, Zhe-Xiong Lian
Lymphatic endothelial cell-mediated accumulation of CD177 + Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma. Oncoimmunology 13 (1) (2024)
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, Lucillia Bezu
Trial watch: dexmedetomidine in cancer therapy. Oncoimmunology 13 (1) (2024)
Margot Revel, Mikel Rezola Artero, Houcine Hamidi, Anne Grunenwald, Loris Blasco, Yann A Vano, Stephane Marie Oudard, Rafael Sanchez-Salas, Petr Macek, Lara Rodriguez Sanchez, Xavier Cathelineau, Benoit Vedié, Catherine Sautes-Fridman, Wolf Herman Fridman, Lubka T Roumenina, Marie-Agnes Dragon-Durey
Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression. Oncoimmunology 13 (1) (2024)
Zoltan Szallasi, Aurel Prosz, Zsofia Sztupinszki, Judit Moldvay
Are tumor-associated carbohydrates the missing link between the gut microbiome and response to immune checkpoint inhibitor treatment in cancer? Oncoimmunology 13 (1) (2024)
Jin Su, Xinyuan Mao, Lingzhi Wang, Zhian Chen, Weisheng Wang, Cuiyin Zhao, Guoxin Li, Weihong Guo, Yanfeng Hu
Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer. Oncoimmunology 13 (1) (2024)
Wei Wei, Linqing Tian, Xiaoyan Zheng, Lei Zhong, Yuan Chen, Hui Dong, Guibing Zhang, Shibing Wang, Xiangmin Tong
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8 + T cell function and its impact against pancreatic ductal adenocarcinoma. Oncoimmunology 13 (1) (2024)